MONTREAL, April 20 /PRNewswire/ - IatroQuest Corporation, a leading
developer of advanced biosensing technologies based in Montreal, Canada, is
pleased to announce the appointment of Mr. Arthur L. Money to the board of
directors of the company.
Mr. Money brings to IatroQuest more than 40 years of management and
engineering experience with the defense electronics industry and intelligence
community. From 1999 to 2001, Mr. Money was Assistant Secretary of Defense for
Command, Control, Communications and Intelligence for the American Government.
He also served as Chief Information Officer for the Department of Defense and
Assistant Secretary of the Air Force for Research, Development and
Acquisition. He was also President of ESL Inc., a subsidiary of TRW that was
consolidated with TRW's Avionics and Surveillance Group.
"Mr. Money will provide IatroQuest with increased visibility and insight
into the US government intelligence community/national security marketplace",
stated John Schafer, CEO of IatroQuest. "His experience and leadership will
help us better serve the needs of the biodefense market, both for military and
civil defense applications, which is one of the primary markets targeted by
IatroQuest for its Bio-Alloy(TM) technology."
"I am enthusiastic about joining the board of a company with such an
exciting technology, which can fill the critical need for biodefense in
America and the world", said Art Money.
IatroQuest Corporation's breakthrough, patented biosensing platform
technology called Bio-Alloy(TM), can rapidly detect and identify a wide range
of biological and chemical agents, without labels and with a high degree of
sensitivity and selectivity. It has specific advantages over similar
technologies to meet the requirements and urgent needs of the biodefense
industry that is resulting from the increase in worldwide terrorism. Recently,
IatroQuest Corporation announced that it has signed a deal with In-Q-Tel, a
private not for profit venture capital group funded by the US Central
Intelligence Agency (CIA) to enhance and customize its Bio-Alloy(TM)
technology to better meet national security needs.
About IatroQuest Corporation
Founded in 1998 and based in Montreal, Canada, IatroQuest Corporation
( www.iatroquest.com ) is shaping the future of biosensing using a
revolutionary patented technological platform called Bio-Alloy(TM), which
combines biotechnology, advanced semi-conductor materials, nanotechnology and
photonics. Bio-Alloy(TM) makes a wide range of products possible in several
market segments, such as biodefense, life sciences research and point-of-care
diagnostics. Bio-Alloy(TM) has unique characteristics that enable rapid
detection and quantification, with a high degree of sensitivity and
specificity without using labels, of a wide range of biological agents as well
as small chemical molecules.
SOURCE IATROQUEST CORPORATION